Sting Capital invests in Encare
Sting Capital has invested SEK 2 million in the Swedish medtech company Encare.
Encare increases efficiency through their web-based software which helps to establish and maintain ERAS (Enhanced Recovery After Surgery), a structured treatment programme that improves the quality and efficiency of the perioperative care.
This is Sting Capital's tenth investment in 2010 and in total the risk capital fund has invested SEK 6.5 million through six follow-up investments and four new investments this year.
Read more
| Fund | Sting Capital I |
| Portfolio Company | Encare |
| Date of Transaction | 2010-07-05 |
| Transaction | Acquisition |
| Seller | |
| Buyer | |
| Size of Transaction | SEK 2.0m |
| Ind. Focus | Life Science |
| Geography | Sweden |
| Stage | Seed |